These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma. Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770 [TBL] [Abstract][Full Text] [Related]
5. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242. Pasanen P; Eskelinen M; Kulju A; Penttilä I; Janatuinen E; Alhava E Scand J Clin Lab Invest; 1995 Apr; 55(2):119-24. PubMed ID: 7667604 [TBL] [Abstract][Full Text] [Related]
6. Predictive power of sexual hormones and tumor markers in endometrial cancer. Kanat-Pektas M; Yenicesu O; Gungor T; Bilge U Arch Gynecol Obstet; 2010 Apr; 281(4):709-15. PubMed ID: 19777250 [TBL] [Abstract][Full Text] [Related]
7. TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer. Medl M; Ogris E; Peters-Engl C; Leodolter S Br J Cancer; 1995 May; 71(5):1051-4. PubMed ID: 7734298 [TBL] [Abstract][Full Text] [Related]
8. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229 [TBL] [Abstract][Full Text] [Related]
9. [The plasma levels and diagnostic utility of stem cell factor in patients with endometrial cancer and myoma uteri]. Ławicki S; Bedkowska GE; Gacuta-Szumarska E; Czygier M; Szmitkowski M Pol Merkur Lekarski; 2009 Jun; 26(156):609-15. PubMed ID: 19711726 [TBL] [Abstract][Full Text] [Related]
10. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder. Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628 [TBL] [Abstract][Full Text] [Related]
11. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer. Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563 [TBL] [Abstract][Full Text] [Related]
12. Serum tetranectin and CA125 in endometrial adenocarcinoma. Lundstrøm MS; Høgdall CK; Nielsen AL; Nyholm HC Anticancer Res; 2000; 20(5C):3903-6. PubMed ID: 11268474 [TBL] [Abstract][Full Text] [Related]
13. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma]. Zhang AM; Zhang P Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745 [TBL] [Abstract][Full Text] [Related]
14. Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma. Yildiz A; Yetimalar H; Kasap B; Aydin C; Tatar S; Soylu F; Yildiz FS Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):191-5. PubMed ID: 22727919 [TBL] [Abstract][Full Text] [Related]
15. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer. Farias-Eisner G; Su F; Robbins T; Kotlerman J; Reddy S; Farias-Eisner R Am J Obstet Gynecol; 2010 Jan; 202(1):73.e1-5. PubMed ID: 19766980 [TBL] [Abstract][Full Text] [Related]
16. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases. Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150 [TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer. Gitsch G; Kainz C; Joura E; Fröhlich B; Bieglmayr C; Tatra G Anticancer Res; 1992; 12(4):1247-9. PubMed ID: 1503417 [TBL] [Abstract][Full Text] [Related]
18. Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy. Koper NP; Massuger LF; Thomas CM; Kiemeney LA; Verbeek AL Anticancer Res; 1998; 18(3B):1897-902. PubMed ID: 9677441 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis. Medl M; Ogris E; Peters-Engl C; Mierau M; Buxbaum P; Leodolter S Br J Obstet Gynaecol; 1997 Jan; 104(1):78-81. PubMed ID: 8988701 [TBL] [Abstract][Full Text] [Related]
20. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma. Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]